Human Genome Content and Gene Structure

Central Dogma and Genotype-Phenotype Architecture

  • The Central Dogma of Molecular Biology (Francis Crick, 1958):

    • DNA (Deoxyribonucleic Acid): Serves as the primary repository for storing genetic information.
    • RNA (Ribonucleic Acid): Acts as the intermediate carrier that transfers genetic information messages from the genome to the cellular machinery.
    • Protein: Executes structural, enzymatic, and regulatory cellular functions based on encoded genetic information.
    • Information Flow: Proceeds via transcription (DNA to RNA) followed by translation (RNA to protein).
  • Hierarchical Organization of Genotype to Phenotype:

    • Genome: The complete set of genetic material (3.1 Gb3.1\,\text{Gb} in the human nuclear genome).
    • Gene Products: Comprises functional proteins and non-coding RNAs (ncRNAs).
    • Gene Networks: Complex regulatory and metabolic interactions among gene products.
    • Cellular Functions: Discrete biological processes executed by gene networks, including:
      • Metabolism
      • Signaling
      • Motility
      • Mitosis
      • Adhesion
      • Stress response
    • Organismal Phenotype: The integrated functional and structural outcome expressed across higher-level anatomical, physiological, and behavioral traits.
    • Organism: The complete biological individual resulting from these hierarchical interactions.

Genotype to Phenotype Hierarchical Pipeline

Quantitative Composition of the Human Genome

  • Haploid Nuclear Genome Size:

    • Total sequence length is approximately 3.1 Gb3.1\,\text{Gb} (3.1×109 base pairs3.1 \times 10^9\,\text{base pairs}).
  • Functional Partitioning of Nuclear DNA Sequence:

    • Protein-Coding Exons: Account for approximately 1.5%1.5\% of total nuclear DNA (roughly 47 Mb47\,\text{Mb}).
    • Introns and Untranslated Regions (UTRs): Comprise approximately 26%26\% of the genome; these regions are transcribed into pre-mRNA and subsequently spliced or trimmed out.
    • Intergenic DNA: Accounts for roughly 72%72\% of the sequence, encompassing regulatory elements, non-coding RNA genes, pseudogenes, and structural spacer regions.
  • Repetitive DNA Sequence Distribution:

    • Approximately 50%50\% of the entire nuclear sequence consists of repetitive elements interspersed throughout introns and intergenic regions rather than clustered in single blocks.
    • Repetitive element families include:
      • LINEs (Long Interspersed Nuclear Elements)
      • SINEs (Short Interspersed Nuclear Elements, such as the Alu family)
      • LTR Transposons (Long Terminal Repeat retrotransposons)
      • DNA Transposon Families
  • Gene and Element Counts in the Human Genome:

    • Protein-Coding Genes: Approximately 20,00020{,}000 genes encoding functional proteins.
    • Non-Coding RNA Genes: Estimated at 20,000 to 25,00020{,}000\,\text{to}\,25{,}000 genes (including tRNAs, rRNAs, snoRNAs, lncRNAs, and miRNAs).
    • Pseudogenes: Tens of thousands of non-functional copies or remnants of genes.
    • Mitochondrial Genome: A distinct 16.6 kb16.6\,\text{kb} (16,569 bp16{,}569\,\text{bp}) circular genome present in dozens of copies per mitochondrion.

Proportions of the Human Nuclear Genome

Genomic Organization and Spatial Clustering

  • Non-Random Distribution of Genes:

    • Human genes are not scattered uniformly throughout the genomic sequence; instead, they exhibit significant density variation and frequently form structural and functional gene clusters.
  • Chromosomal Organization Example (Chromosome 11):

    • Olfactory Receptor (OROR) Gene Clusters: Multiple clusters of olfactory receptor genes are distributed across chromosome 11 (e.g., at genomic positions around 5.15 Mb5.15\,\text{Mb}, 5.2 Mb5.2\,\text{Mb}, and 5.35 Mb5.35\,\text{Mb}).
    • β\beta-like Globin Gene Cluster: Located within a 60 kb60\,\text{kb} span (around 5.25 to 5.30 Mb5.25\,\text{to}\,5.30\,\text{Mb} on Chromosome 11), containing functional globin genes organized in developmental sequence:
      • ϵ\epsilon (embryonic)
      • Gγ^{G}\gamma and Aγ^{A}\gamma (fetal)
      • δ\delta and β\beta (adult)
    • Locus Control Region (LCR): An essential upstream regulatory region that coordinates the tissue-specific and developmentally regulated expression of the entire β\beta-like globin gene cluster.

Human Chromosome 11 Gene Cluster Map showing Olfactory Receptors and Beta-Globin Cluster

Generic Anatomy of a Human Protein-Coding Gene

  • Transcriptional Orientation:

    • Transcribed in the 5′ to 3′5'\,\text{to}\,3' direction relative to the coding (sense) strand of DNA.
  • Upstream Regulatory Regions:

    • Promoter: Located immediately upstream of the transcription start site (TSSTSS); serves as the core binding platform for RNA polymerase II and general transcription factors.
    • CAT Box (CCAAT): Prominent promoter motif bound by specific transcription factors to increase transcription efficiency.
    • TATA Box (TATAAA): Upstream promoter element that binds TATA-binding protein (TBP) to establish the exact transcriptional start coordinate.
    • CpG Islands: Genomic regions with high density of the dinucleotide 5′-CpG-3′5'\text{-CpG-}3', frequently overlapping promoter regions of constitutive or regulated genes.
    • Enhancers: Cis-acting DNA sequences that can be located upstream, downstream, or within introns to boost transcriptional activity.
    • Locus Control Regions (LCR): Complex regulatory regions that open local chromatin domain structure to permit high-level expression of clustered genes.
  • Structural Elements of the Transcribed Region:

    • Transcription Start Site (TSS): The precise base position (+1+1) where RNA synthesis initiates.
    • 5′5' Untranslated Region (5′-UTR5'\text{-UTR}): Transcribed sequence located between the TSS and the initiator codon; involved in translational regulation and mRNA stability.
    • Initiator Codon: The trinucleotide sequence 5′-AUG-3′5'\text{-AUG-}3' (encoding Methionine) where translation begins.
    • Exons: Coding and untranslated genomic segments that are transcribed and retained in mature mRNA.
    • Introns (Intervening Sequences): Non-coding genomic regions located between exons that are transcribed into primary RNA transcripts but removed during splicing.
    • Splice Junction Boundaries: Highly conserved consensus sequences marking intron ends:
      • 5′5' Donor Splice Site: Characterized by a invariant 5′-GT-3′5'\text{-GT-}3' sequence at the start of the intron.
      • 3′3' Acceptor Splice Site: Characterized by an invariant 5′-AG-3′5'\text{-AG-}3' sequence at the end of the intron.
    • Termination Codon: Trinucleotide stop sequence (5′-UAA-3′5'\text{-UAA-}3', 5′-UAG-3′5'\text{-UAG-}3', or 5′-UGA-3′5'\text{-UGA-}3') that signals the termination of peptide translation.
    • 3′3' Untranslated Region (3′-UTR3'\text{-UTR}): Transcribed sequence located downstream of the termination codon that regulates mRNA stability, localization, and polyadenylation.
    • Polyadenylation Signal: A conserved genomic motif (5′-AATAAA-3′5'\text{-AATAAA-}3' in DNA; 5′-AAUAAA-3′5'\text{-AAUAAA-}3' in RNA) that directs endonucleolytic cleavage and poly(A) tail addition.

Structural Architecture of a Generic Human Protein-Coding Gene

Diversity in Gene Architecture and Complexity

  • Structural Variation Across Human Genes:

    • Human genes exhibit massive variation in overall length, exon number, promoter composition, and intron size.
  • Representative Comparative Gene Models:

    • β\beta-Globin (HBBHBB):
      • Compact structure spanning approximately 1.6 kb1.6\,\text{kb}.
      • Contains 33 exons and 22 introns.
      • Driven by standard promoter motifs including CAT and TATA boxes.
    • Breast Cancer Type 1 (BRCA1BRCA1):
      • Large tumor suppressor gene spanning approximately 80 kb80\,\text{kb}.
      • Contains 2424 exons separated by variable introns.
      • Promoter resides within a dedicated CG-rich CpG island.
    • Myosin Heavy Chain 7 (MYH7MYH7):
      • Encodes a primary cardiac muscle structural protein spanning approximately 23 kb23\,\text{kb}.
      • Exhibits high splicing complexity with 4040 distinct exons.

Gene Structural Comparison of HBB, BRCA1, and MYH7

Biogenesis and Classification of Pseudogenes

  • Definition:

    • Pseudogenes are non-functional DNA sequences that display high sequence homology to functional protein-coding genes but have lost the ability to produce functional proteins.
  • Classification of Pseudogenes:

    • Classical (Non-Processed) Pseudogenes:
      • Mechanism: Arise via genomic DNA duplication events.
      • Evolutionary Fate: Over time, one duplicated gene copy accumulates deleterious mutations that render it non-functional while the original copy remains active.
      • Structural Features: Retain the original gene architecture, including preserved intron sequences and upstream promoter remnants.
    • Processed Pseudogenes:
      • Mechanism: Formed via retrotransposition; an mRNA transcript undergoes reverse transcription into complementary DNA (cDNA) by a retrotransposon reverse transcriptase and re-integrates into genomic DNA at a new location.
      • Structural Features: Characterized by a complete absence of introns, presence of a poly(A) tail remnant, and lack of native upstream promoter elements.
  • Common Molecular Defects Inactivating Pseudogenes:

    • Missing promoter sequence
    • Missing start (initiator) codon
    • Frameshift mutations (insertions or deletions altering reading frame)
    • Premature stop codons (nonsense mutations)
    • Absence of internal introns (processed type)
    • Partial genomic deletions

Mechanisms of Classical and Processed Pseudogenes FormationCommon Structural Defects Inactivating Pseudogenes

Taxonomy and Biological Functions of Non-Coding RNAs

  • Classification by Size:

    • Non-coding RNAs (ncRNAs) are functional RNA transcripts that do not code for proteins, divided into two primary size classes encompassing more than 3030 recognized subclasses.
  • Small Non-Coding RNAs (18 to 200 nucleotides18\,\text{to}\,200\,\text{nucleotides}; 19 subclasses):

    • tRNAs (Transfer RNAs): Adaptor molecules that deliver specific amino acids to ribosomes during protein translation.
    • miRNAs (MicroRNAs): Short (∼22 nt\sim 22\,\text{nt}) RNAs that direct post-transcriptional gene silencing by binding target mRNA UTRs to inhibit translation or promote decay.
    • rRNAs (Ribosomal 5S5\text{S} and 5.8S5.8\text{S} RNAs): Structural and catalytic RNA components of ribosome subunits.
    • piRNAs (Piwi-Interacting RNAs): Small RNAs that associate with Piwi proteins to suppress transposon mobilization in germline cells.
    • siRNAs (Small Interfering RNAs): Double-stranded short RNAs involved in sequence-specific RNA interference and gene silencing.
    • snoRNAs (Small Nucleolar RNAs): Guide site-specific chemical modifications (e.g., methylation, pseudouridylation) of rRNAs and other nuclear RNAs.
    • snRNAs (Small Nuclear RNAs): Core RNA components of spliceosomes (U1,U2,U4,U5,U6\text{U1}, \text{U2}, \text{U4}, \text{U5}, \text{U6}) that catalyze pre-mRNA intron removal.
    • Additional Recognized Small ncRNA Subclasses:
      • tiRNAstiRNAs (Tiny transcription initiation RNAs)
      • PASRsPASRs (Promoter-associated short RNAs)
      • TASRsTASRs (Termini-associated short RNAs)
      • aTASRsaTASRs (Antisense termini-associated RNAs)
      • TSSa-RNAsTSSa\text{-RNAs} (Transcription start site antisense RNAs)
      • RE-RNAsRE\text{-RNAs} (Retrotransposon-derived RNAs)
      • uaRNAsuaRNAs (3′-UTR3'\text{-UTR} derived RNAs)
      • x-ncRNAx\text{-ncRNA}
      • hY RNAhY\text{ RNA} (Human Y RNA)
      • usRNAsusRNAs (Unusually small RNAs)
      • snaRssnaRs (Small NF90-associated RNAs)
      • vtRNAsvtRNAs (Vault RNAs)
  • Long Non-Coding RNAs (lncRNAs; 200 nt to >100 kb200\,\text{nt}\,\text{to}\,>100\,\text{kb}; 11 subclasses):

    • rRNAs (Ribosomal 18S18\text{S} and 28S28\text{S} RNAs): Primary structural and catalytic RNA frameworks of the small and large ribosomal subunits.
    • lincRNAs (Long Intergenic Non-Coding RNAs): Autonomous non-coding transcripts located between protein-coding genes that regulate chromatin architecture and transcription.
    • aRNAs (Antisense RNAs): Transcripts produced from the opposite strand of protein-coding loci that regulate gene expression.
    • Transcribed Pseudogene RNAs: Non-coding transcripts produced from pseudogene loci that can regulate parental gene expression.
    • Additional Recognized Long ncRNA Subclasses:
      • T-UCRsT\text{-UCRs} (Transcribed ultraconserved regions)
      • GRC-RNAsGRC\text{-RNAs} (GAA-repeat containing RNAs)
      • Long intronic ncRNAs
      • PALRsPALRs (Promoter-associated long RNAs)
      • PROMPTsPROMPTs (Promoter upstream transcripts)
      • Stable excised intron RNAs
      • LSINCTsLSINCTs (Long stress-induced transcripts)

Clinical Significance of Non-Coding RNA Mutations

  • Pathogenic Role of ncRNA Alterations:

    • Variants, deletions, or dysregulation of non-coding RNA loci cause diverse human congenital and developmental disorders.
  • Feingold Syndrome 2 Case Study:

    • Genomic Cause: Hemizygous microdeletion on chromosome 13q31.313\text{q}31.3 encompassing a specific cluster of miRNA genes, specifically the MIR17HGMIR17HG locus (encoding the miR-17~92 cluster).
    • Clinical Features:
      • Microcephaly (reduced head circumference)
      • Dysmorphic facial features
      • Brachydactyly (short fingers/toes)
      • Syndactyly (fused digits of hands/feet)
      • Short stature

Feingold Syndrome 2 Clinical Features and Chromosome 13 Microdeletion Map

Stages and Subcellular Locations of Gene Expression

  • 1. Transcription (Nuclear):

    • RNA Polymerase II binds the gene promoter and uses the antisense (template) strand to synthesize a complementary primary pre-mRNA transcript in the 5′ to 3′5'\,\text{to}\,3' direction.
    • A 7-methylguanosine7\text{-methylguanosine} cap is added to the 5′5' end during early transcription (5′5' capping).
  • 2. RNA Processing and Splicing (Nuclear):

    • Spliceosomes recognize conserved splice sites (GTGT donor at 5′5' intron edge; AGAG acceptor at 3′3' intron edge) to excise non-coding introns and join exons.
    • Endonucleolytic cleavage occurs downstream of the 5′-AAUAAA-3′5'\text{-AAUAAA-}3' polyadenylation signal in the 3′-UTR3'\text{-UTR}, followed by enzymatic addition of a poly(A) tail (polyApolyA addition).
  • 3. Nuclear Transport (Nucleus to Cytoplasm):

    • Fully processed mature mRNA (containing 5′5' cap, joined exons, UTRs, and 3′3' poly(A) tail) is exported through nuclear pore complexes into the cytoplasm.
  • 4. Translation (Cytoplasmic):

    • Ribosomes assemble on the mature mRNA near the 5′5' cap and scan for the initiator codon (5′-AUG-3′5'\text{-AUG-}3').
    • tRNAs deliver specific amino acids corresponding to triplet mRNA codons along the open reading frame.
  • 5. Protein Assembly (Cytoplasmic):

    • The growing polypeptide chain exits the ribosome and folds into its tertiary spatial conformation to produce a functional protein.

Nuclear Events in Gene Expression: Transcription and CappingPost-Transcriptional and Translational Events of Gene Expression

Structure and Properties of the Genetic Code

  • Triplet Codon Structure:

    • The genetic code is read sequentially in non-overlapping nucleotide triplets (codons) from the 5′ to 3′5'\,\text{to}\,3' direction on mRNA.
  • Degeneracy of the Genetic Code:

    • Most of the 20 standard amino acids are specified by more than one triplet codon.
    • Exceptions: Methionine (5′-AUG-3′5'\text{-AUG-}3') and Tryptophan (5′-UGG-3′5'\text{-UGG-}3') are unique in being encoded by single codons.
  • Start and Stop Signals:

    • Initiator Codon: 5′-AUG-3′5'\text{-AUG-}3' establishes the open reading frame (ORF) and specifies Methionine.
    • Termination Codons: Three non-coding stop codons terminate translation:
      • 5′-UAA-3′5'\text{-UAA-}3'
      • 5′-UAG-3′5'\text{-UAG-}3'
      • 5′-UGA-3′5'\text{-UGA-}3'
  • Consequences of Single-Base Substitutions (Point Mutations):

    • Synonymous (Silent) Mutations: Base change yields a redundant codon encoding the identical amino acid due to code degeneracy (often occurring at the 3rd codon base position).
    • Nonsynonymous (Missense) Mutations: Base change alters the codon to specify a structurally or chemically distinct amino acid.
    • Nonsense Mutations: Base change converts an amino acid codon into a premature stop codon (UAAUAA, UAGUAG, or UGAUGA), causing premature polypeptide chain termination.

Circular Genetic Code Chart

Detailed Molecular Case Study: Human Beta-Globin Gene (HBBHBB)

  • Gene Structure and Regulatory Elements:

    • Promoter Sequence Elements:
      • CAT Box: 5′-ccaat-3′5'\text{-ccaat-}3' sequence bound by transcription factor complexes.
      • TATA Box: 5′-ataaaa-3′5'\text{-ataaaa-}3' sequence bound by TBP.
    • Exon-Intron Architecture:
      • Contains 3 exons and 2 intervening introns.
      • Intron 1 bounded by 5′-gt-3′5'\text{-gt-}3' donor and 3′-ag-3′3'\text{-ag-}3' acceptor splice signals.
      • Intron 2 bounded by 5′-gt-3′5'\text{-gt-}3' donor and 3′-ag-3′3'\text{-ag-}3' acceptor splice signals.
    • Translation Start: Initiator codon 5′-ATG-3′5'\text{-ATG-}3' located in Exon 1.
    • Translation Termination: Stop codon 5′-TAA-3′5'\text{-TAA-}3' located in Exon 3.
    • Polyadenylation Signal: 5′-AATAAA-3′5'\text{-AATAAA-}3' located in the 3′-UTR3'\text{-UTR} of Exon 3.
  • DNA to RNA Sequence Trace:

    • Sense DNA Sequence (Partial):
      • 5′…TATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCACCTGACTCCTGAGGAGAAGTCTGCC…3′5'\text{\dots TATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCACCTGACTCCTGAGGAGAAGTCTGCC\dots }3'
    • Antisense DNA Sequence (Template):
      • 3′…ATAACGAATGTAAACGAAGACTGTGTTGACACAAGTGATCGTTGGAGTTTGTCTGTGGTACCACGTGGACTGAGGACTCCTCTTCAGACGG…5′3'\text{\dots ATAACGAATGTAAACGAAGACTGTGTTGACACAAGTGATCGTTGGAGTTTGTCTGTGGTACCACGTGGACTGAGGACTCCTCTTCAGACGG\dots }5'
    • Transcribed mRNA Sequence:
      • 5'\text{\dots ACAUUUGCUUCUGACACAACUGUGUUCACUAGCAACCUCAAACAGACACCA\mathbf{UGG\,UGC\,ACC\,UGA\,CUC\,CUG\,AGG\,AGA\,AGU\,CUG\,CC}\dots }3'
  • Translated Polypeptide Sequence:

    • Reading frame starts at AUG (Met\text{Met} cleared post-translationally) to yield initial β\beta-globin amino acids:
      • Val - His - Leu - Thr - Pro - Glu - Glu - Lys - Ser - Ala…\text{Val - His - Leu - Thr - Pro - Glu - Glu - Lys - Ser - Ala}\dots
  • Disruption of Gene Expression Steps by Variants:

    • Promoter Variants (CAT or TATA Box mutations): Disrupt transcription factor binding, causing reduced transcription initiation rates.
    • Splice Site Variants (GT or AG mutations at boundaries): Cause intron retention or cryptic splice site activation, disrupting normal splicing.
    • Polyadenylation Signal Variants (AATAAA mutations): Impair pre-mRNA cleavage and polyadenylation, yielding unstable transcripts.
    • Clinical Phenotype: Variants affecting any of these regulatory/processing steps reduce or eliminate β\beta-globin synthesis, resulting in β\beta-thalassemia.

Transcription and Translation Alignment of HBB DNA to Protein

Comparative Structure and Genetics of the Mitochondrial Genome

  • Structural Parameters of Human Mitochondrial DNA (mtDNA):

    • Structure: Circular double-stranded DNA molecule.
    • Size: Exactly 16,569 bp16{,}569\,\text{bp} (∼16.6 kb\sim 16.6\,\text{kb}).
    • Copy Number: Dozens of identical mtDNA molecules per mitochondrion, totaling hundreds to thousands per cell.
  • Mode of Inheritance:

    • Exclusively maternal inheritance; sperm mitochondria are degraded or excluded upon fertilization, leaving only egg mitochondria in the developing zygote.
  • Gene Content (3737 Genes Total):

    • Protein-Coding Genes (1313 genes): Encodes essential subunits of oxidative phosphorylation complexes:
      • Complex I: ND1ND1, ND2ND2, ND3ND3, ND4ND4, ND4LND4L, ND5ND5, ND6ND6
      • Complex III: Cyt bCyt\,b
      • Complex IV: Cox1Cox1, Cox2Cox2, Cox3Cox3
      • Complex V: ATP6ATP6, ATP8ATP8
    • Transfer RNA Genes (2222 tRNAs): Encodes full complement of tRNAs necessary for intramitochondrial translation.
    • Ribosomal RNA Genes (22 rRNAs): Encodes 12S12\text{S} rRNA and 16S16\text{S} rRNA subunits.
    • Control Region (D-Loop): Non-coding regulatory zone containing origins of replication and transcriptional promoters.
  • Pathology:

    • Pathogenic mutations or deletions in mitochondrial DNA disrupt cellular ATP production and produce complex multi-system mitochondrial disorders.

Structural Map of Human Mitochondrial DNA

Allelic Expression Dynamics and Allelic Imbalance

  • Definition:

    • Heterozygous single nucleotide polymorphisms (SNPs) within exon sequences allow distinct tracking of maternal and paternal mRNA transcripts.
  • Expression Patterns:

    • Balanced Expression: Both alleles (e.g., CC and TT in DNA; GG and AA in RNA) are transcribed and maintained at equal stoichiometric ratios (G=AG = A).
    • Allelic Imbalance: Transcriptional output or mRNA stability is skewed toward one allele, causing unequal expression ratios (G>AG > A or A>GA > G).
    • Monoallelic Expression: Only one allele is detectably expressed while the second allele is silenced (A onlyA\,\text{only} or G onlyG\,\text{only}), occurring in phenomena such as genomic imprinting or X-chromosome inactivation.

Mechanisms of Allelic Imbalance and Monoallelic Gene Expression